Desferal 00078-0467-91
Generic: Deferoxamine Mesylate
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 2, 1968
- Listing Expires
- December 31, 2026
- Application
- NDA016267
Need to source Desferal? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferoxamine Mesylate | 500 mg/1 |
Drug Class
Iron Chelating Activity [MoA]Iron Chelator [EPC]
Selected Package
00078-0467-91Selected4 VIAL in 1 CARTON (0078-0467-91) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0467-61)